Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bipin N Savani

Showing results (1-10 of 406) with videos related to

Pageof 41
Sort By:
Cytotherapy|August 18, 2011
Can we modify transplant outcome by improving lymphocyte recovery?Bipin N Savani
Seminars in Hematology|January 7, 2012
How can we improve life expectancy and quality of life in long-term survivors after allogeneic stem cell transplantation?Bipin N Savani
Blood|August 31, 2013
Ferritin and FerriScan in HCT recipientsBipin N Savani
Blood|September 18, 2010
Transplantation in AML CR1Bipin N Savani
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2011
Treatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approachNishitha Reddy, Bipin N Savani
European Journal of Haematology|April 29, 2014
Impact of risk score calculations in choosing front-line tyrosine kinase inhibitors for patients with newly diagnosed chronic myeloid leukemia in the chronic phaseBei Hu, Bipin N Savani
British Journal of Haematology|July 27, 2020
Prognostic scoring system after transplantation in myeloma: predicting early relapseMeral Beksac, Bipin N Savani
Cellular Immunology|June 9, 2012
The role of nutrition and effects on the cytokine milieu in allogeneic hematopoietic stem cell transplantationLauren Zatarain, Bipin N Savani
Cytotherapy|February 8, 2014
Age is more than a numberSalyka Sengsayadeth, Bipin N Savani
Seminars in Hematology|March 23, 2016
Introduction: Why alternative donor transplantation and what are the different options and current challenges?Bipin N Savani, Mohamad Mohty
Pageof 41

Showing results (1-10 of 406) with videos related to

Sort By:
Pageof 41
Cytotherapy|August 18, 2011
Can we modify transplant outcome by improving lymphocyte recovery?Bipin N Savani
Seminars in Hematology|January 7, 2012
How can we improve life expectancy and quality of life in long-term survivors after allogeneic stem cell transplantation?Bipin N Savani
Blood|August 31, 2013
Ferritin and FerriScan in HCT recipientsBipin N Savani
Blood|September 18, 2010
Transplantation in AML CR1Bipin N Savani
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2011
Treatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approachNishitha Reddy, Bipin N Savani
European Journal of Haematology|April 29, 2014
Impact of risk score calculations in choosing front-line tyrosine kinase inhibitors for patients with newly diagnosed chronic myeloid leukemia in the chronic phaseBei Hu, Bipin N Savani
British Journal of Haematology|July 27, 2020
Prognostic scoring system after transplantation in myeloma: predicting early relapseMeral Beksac, Bipin N Savani
Cellular Immunology|June 9, 2012
The role of nutrition and effects on the cytokine milieu in allogeneic hematopoietic stem cell transplantationLauren Zatarain, Bipin N Savani
Cytotherapy|February 8, 2014
Age is more than a numberSalyka Sengsayadeth, Bipin N Savani
Seminars in Hematology|March 23, 2016
Introduction: Why alternative donor transplantation and what are the different options and current challenges?Bipin N Savani, Mohamad Mohty
Pageof 41